Polymerase chain reaction (PCR) is a molecular biology technique used to amplify and detect specific DNA or RNA sequences. It is widely used in various applications, including genetic testing, diagnostic assays, and research.
The global market for Polymerase Chain Reaction (PCR) was estimated to be worth US$ 6295.5 million in 2023 and is forecast to a readjusted size of US$ 8868.3 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030
The market for polymerase chain reaction (PCR) is driven by the demand for sensitive and specific molecular diagnostic solutions and the growing applications of PCR in infectious disease testing, genomics, and personalized medicine. The market's growth is also influenced by advancements in PCR technology, such as real-time PCR and digital PCR.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polymerase Chain Reaction (PCR), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Polymerase Chain Reaction (PCR) by region & country, by Type, and by Application.
The Polymerase Chain Reaction (PCR) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymerase Chain Reaction (PCR).
麻豆原创 Segmentation
By Company
Bio-Rad
QIAGEN
Roche
Thermo Fisher
BD
Abbott
Siemens
bioM茅rieux SA
Danaher
Agilent Technologies
Sansure Biotech
BGI Genomics
Wondfo Biotech
Hybribio Biotech
Lepu Medical
Amoy Diagnostics
Xilong Scientific
ZJ Bio-Tech Co., Ltd.
Tellgen Corporation
Bioperfectus Technologies
Kehua Bio-Engineering
EasyDiagnosis
Dian Diagnostics
Segment by Type:
Instruments
Reagents & Consumables
Software & Services
Segment by Application
Clinical Diagnostics
Life Sciences
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Polymerase Chain Reaction (PCR) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Polymerase Chain Reaction (PCR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Polymerase Chain Reaction (PCR) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Polymerase Chain Reaction (PCR) Product Introduction
1.2 Global Polymerase Chain Reaction (PCR) 麻豆原创 Size Forecast
1.3 Polymerase Chain Reaction (PCR) 麻豆原创 Trends & Drivers
1.3.1 Polymerase Chain Reaction (PCR) Industry Trends
1.3.2 Polymerase Chain Reaction (PCR) 麻豆原创 Drivers & Opportunity
1.3.3 Polymerase Chain Reaction (PCR) 麻豆原创 Challenges
1.3.4 Polymerase Chain Reaction (PCR) 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Polymerase Chain Reaction (PCR) Players Revenue Ranking (2023)
2.2 Global Polymerase Chain Reaction (PCR) Revenue by Company (2019-2024)
2.3 Key Companies Polymerase Chain Reaction (PCR) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Polymerase Chain Reaction (PCR) Product Offered
2.5 Key Companies Time to Begin Mass Production of Polymerase Chain Reaction (PCR)
2.6 Polymerase Chain Reaction (PCR) 麻豆原创 Competitive Analysis
2.6.1 Polymerase Chain Reaction (PCR) 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Polymerase Chain Reaction (PCR) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymerase Chain Reaction (PCR) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Instruments
3.1.2 Reagents & Consumables
3.1.3 Software & Services
3.2 Global Polymerase Chain Reaction (PCR) Sales Value by Type
3.2.1 Global Polymerase Chain Reaction (PCR) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Polymerase Chain Reaction (PCR) Sales Value, by Type (2019-2030)
3.2.3 Global Polymerase Chain Reaction (PCR) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinical Diagnostics
4.1.2 Life Sciences
4.1.3 Others
4.2 Global Polymerase Chain Reaction (PCR) Sales Value by Application
4.2.1 Global Polymerase Chain Reaction (PCR) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Polymerase Chain Reaction (PCR) Sales Value, by Application (2019-2030)
4.2.3 Global Polymerase Chain Reaction (PCR) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Polymerase Chain Reaction (PCR) Sales Value by Region
5.1.1 Global Polymerase Chain Reaction (PCR) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Polymerase Chain Reaction (PCR) Sales Value by Region (2019-2024)
5.1.3 Global Polymerase Chain Reaction (PCR) Sales Value by Region (2025-2030)
5.1.4 Global Polymerase Chain Reaction (PCR) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
5.2.2 North America Polymerase Chain Reaction (PCR) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
5.3.2 Europe Polymerase Chain Reaction (PCR) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
5.4.2 Asia Pacific Polymerase Chain Reaction (PCR) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
5.5.2 South America Polymerase Chain Reaction (PCR) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
5.6.2 Middle East & Africa Polymerase Chain Reaction (PCR) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Polymerase Chain Reaction (PCR) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Polymerase Chain Reaction (PCR) Sales Value
6.3 United States
6.3.1 United States Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
6.3.2 United States Polymerase Chain Reaction (PCR) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Polymerase Chain Reaction (PCR) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
6.4.2 Europe Polymerase Chain Reaction (PCR) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Polymerase Chain Reaction (PCR) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
6.5.2 China Polymerase Chain Reaction (PCR) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Polymerase Chain Reaction (PCR) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
6.6.2 Japan Polymerase Chain Reaction (PCR) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Polymerase Chain Reaction (PCR) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
6.7.2 South Korea Polymerase Chain Reaction (PCR) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Polymerase Chain Reaction (PCR) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
6.8.2 Southeast Asia Polymerase Chain Reaction (PCR) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Polymerase Chain Reaction (PCR) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Polymerase Chain Reaction (PCR) Sales Value, 2019-2030
6.9.2 India Polymerase Chain Reaction (PCR) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Polymerase Chain Reaction (PCR) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bio-Rad
7.1.1 Bio-Rad Profile
7.1.2 Bio-Rad Main Business
7.1.3 Bio-Rad Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.1.4 Bio-Rad Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.1.5 Bio-Rad Recent Developments
7.2 QIAGEN
7.2.1 QIAGEN Profile
7.2.2 QIAGEN Main Business
7.2.3 QIAGEN Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.2.4 QIAGEN Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.2.5 QIAGEN Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.3.4 Roche Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.3.5 Thermo Fisher Recent Developments
7.4 Thermo Fisher
7.4.1 Thermo Fisher Profile
7.4.2 Thermo Fisher Main Business
7.4.3 Thermo Fisher Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.4.4 Thermo Fisher Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.4.5 Thermo Fisher Recent Developments
7.5 BD
7.5.1 BD Profile
7.5.2 BD Main Business
7.5.3 BD Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.5.4 BD Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.5.5 BD Recent Developments
7.6 Abbott
7.6.1 Abbott Profile
7.6.2 Abbott Main Business
7.6.3 Abbott Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.6.4 Abbott Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.6.5 Abbott Recent Developments
7.7 Siemens
7.7.1 Siemens Profile
7.7.2 Siemens Main Business
7.7.3 Siemens Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.7.4 Siemens Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.7.5 Siemens Recent Developments
7.8 bioM茅rieux SA
7.8.1 bioM茅rieux SA Profile
7.8.2 bioM茅rieux SA Main Business
7.8.3 bioM茅rieux SA Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.8.4 bioM茅rieux SA Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.8.5 bioM茅rieux SA Recent Developments
7.9 Danaher
7.9.1 Danaher Profile
7.9.2 Danaher Main Business
7.9.3 Danaher Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.9.4 Danaher Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.9.5 Danaher Recent Developments
7.10 Agilent Technologies
7.10.1 Agilent Technologies Profile
7.10.2 Agilent Technologies Main Business
7.10.3 Agilent Technologies Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.10.4 Agilent Technologies Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.10.5 Agilent Technologies Recent Developments
7.11 Sansure Biotech
7.11.1 Sansure Biotech Profile
7.11.2 Sansure Biotech Main Business
7.11.3 Sansure Biotech Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.11.4 Sansure Biotech Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.11.5 Sansure Biotech Recent Developments
7.12 BGI Genomics
7.12.1 BGI Genomics Profile
7.12.2 BGI Genomics Main Business
7.12.3 BGI Genomics Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.12.4 BGI Genomics Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.12.5 BGI Genomics Recent Developments
7.13 Wondfo Biotech
7.13.1 Wondfo Biotech Profile
7.13.2 Wondfo Biotech Main Business
7.13.3 Wondfo Biotech Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.13.4 Wondfo Biotech Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.13.5 Wondfo Biotech Recent Developments
7.14 Hybribio Biotech
7.14.1 Hybribio Biotech Profile
7.14.2 Hybribio Biotech Main Business
7.14.3 Hybribio Biotech Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.14.4 Hybribio Biotech Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.14.5 Hybribio Biotech Recent Developments
7.15 Lepu Medical
7.15.1 Lepu Medical Profile
7.15.2 Lepu Medical Main Business
7.15.3 Lepu Medical Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.15.4 Lepu Medical Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.15.5 Lepu Medical Recent Developments
7.16 Amoy Diagnostics
7.16.1 Amoy Diagnostics Profile
7.16.2 Amoy Diagnostics Main Business
7.16.3 Amoy Diagnostics Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.16.4 Amoy Diagnostics Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.16.5 Amoy Diagnostics Recent Developments
7.17 Xilong Scientific
7.17.1 Xilong Scientific Profile
7.17.2 Xilong Scientific Main Business
7.17.3 Xilong Scientific Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.17.4 Xilong Scientific Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.17.5 Xilong Scientific Recent Developments
7.18 ZJ Bio-Tech Co., Ltd.
7.18.1 ZJ Bio-Tech Co., Ltd. Profile
7.18.2 ZJ Bio-Tech Co., Ltd. Main Business
7.18.3 ZJ Bio-Tech Co., Ltd. Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.18.4 ZJ Bio-Tech Co., Ltd. Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.18.5 ZJ Bio-Tech Co., Ltd. Recent Developments
7.19 Tellgen Corporation
7.19.1 Tellgen Corporation Profile
7.19.2 Tellgen Corporation Main Business
7.19.3 Tellgen Corporation Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.19.4 Tellgen Corporation Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.19.5 Tellgen Corporation Recent Developments
7.20 Bioperfectus Technologies
7.20.1 Bioperfectus Technologies Profile
7.20.2 Bioperfectus Technologies Main Business
7.20.3 Bioperfectus Technologies Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.20.4 Bioperfectus Technologies Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.20.5 Bioperfectus Technologies Recent Developments
7.21 Kehua Bio-Engineering
7.21.1 Kehua Bio-Engineering Profile
7.21.2 Kehua Bio-Engineering Main Business
7.21.3 Kehua Bio-Engineering Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.21.4 Kehua Bio-Engineering Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.21.5 Kehua Bio-Engineering Recent Developments
7.22 EasyDiagnosis
7.22.1 EasyDiagnosis Profile
7.22.2 EasyDiagnosis Main Business
7.22.3 EasyDiagnosis Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.22.4 EasyDiagnosis Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.22.5 EasyDiagnosis Recent Developments
7.23 Dian Diagnostics
7.23.1 Dian Diagnostics Profile
7.23.2 Dian Diagnostics Main Business
7.23.3 Dian Diagnostics Polymerase Chain Reaction (PCR) Products, Services and Solutions
7.23.4 Dian Diagnostics Polymerase Chain Reaction (PCR) Revenue (US$ Million) & (2019-2024)
7.23.5 Dian Diagnostics Recent Developments
8 Industry Chain Analysis
8.1 Polymerase Chain Reaction (PCR) Industrial Chain
8.2 Polymerase Chain Reaction (PCR) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Polymerase Chain Reaction (PCR) Sales Model
8.5.2 Sales Channel
8.5.3 Polymerase Chain Reaction (PCR) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Bio-Rad
QIAGEN
Roche
Thermo Fisher
BD
Abbott
Siemens
bioM茅rieux SA
Danaher
Agilent Technologies
Sansure Biotech
BGI Genomics
Wondfo Biotech
Hybribio Biotech
Lepu Medical
Amoy Diagnostics
Xilong Scientific
ZJ Bio-Tech Co., Ltd.
Tellgen Corporation
Bioperfectus Technologies
Kehua Bio-Engineering
EasyDiagnosis
Dian Diagnostics
听
听
*If Applicable.